[Hepatitis B revaccination not indicated, even for those at increased risk]

Area of Science:

• Immunology
• Vaccinology
• Public Health

Context:

• Hepatitis B virus (HBV) infection poses a significant global health risk.
• Vaccination is the primary strategy for preventing HBV infection.
• Long-term efficacy and the need for booster doses in vaccinated individuals remain areas of investigation.

Purpose:

• To evaluate the long-term protection conferred by hepatitis B vaccination.
• To determine if revaccination is necessary after 15 years, particularly for individuals with increased occupational risk of HBV infection.

Summary:

• A systematic literature review analyzed 30 studies from 2002-2008, including follow-up periods exceeding 15 years.
• Seroconversion rates (anti-HBc and HBsAg) were consistently low (<1.78%) and did not increase significantly over time post-vaccination.
• No clinical signs or symptoms were associated with observed seroconversions, indicating a lack of breakthrough infections.

Impact:

• Findings suggest that hepatitis B vaccination offers durable protection for at least 23 years.
• Revaccination after 15 years appears unnecessary for successfully vaccinated individuals, even those with occupational risk.
• This research supports current vaccination schedules and may inform future public health recommendations regarding hepatitis B prevention.